Closed
SectorHealthcare
11.47 3.33
24h
Min
11.42
Max
11.56
Income | 9.3M -85M |
---|---|
Sales | 12M 20M |
EPS | -0.985 |
Profit margin | -423.341 |
Employees | 270 |
EBITDA | 5.6M -84M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +175.11% upside |
Next Earnings | 31 lip 2025 |
---|
Market Cap | -237M 945M |
---|---|
Previous open | 8.14 |
Previous close | 11.47 |
By Acuity
67%
33%
342 / 380 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 31.5 USD 175.11%
High 45 USD
Low 17 USD
Based on 7 Wall Street analysts offering 12 month price targets forSyndax Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$